Smart + Strong.
All Rights Reserved.
Smart + Strong®
is a registered trademark of CDM Publishing, LLC.
A new lawsuit accuses the imprisoned hedge funder of blocking generic rivals of an AIDS-related drug.
Here is a fantastic story from Jonathan Nakamoto in the USA who treated and cured his hepatitis C with generic Harvoni from India in 2016.
At the center of the lawsuit is Teva Pharmaceutical, slated to sell a generic version of the HIV prevention pill PrEP next year.
The head of the Food and Drug Administration cited a long commute and time away from family as reasons to step down.
The high cost of hepatitis C treatment in the U.S. is about to see a major shift to lower prices of the major leading hepatitis C treatments
The drugs are set to come out in January 2019 with a list price of $24,000 for the most common dose for each.
This Ukrainian woman didn’t let outdated hepatitis C treatment or limited access to them, prevent her from getting necessary medical care.
Stocks of drug companies are rising—and that’s not a good sign for consumers.
Invoking a 100-year-old law that was implemented to serve folks in a time of crisis.
Research from the 2016 Liver Meeting
Groups purchasing treatment from buyers’ clubs do well on the drugs.
A discussion about insurance coverage of hepatitis C treatment
Generic versions of major hepatitis C drugs are apparently very effective.
Researchers are launching trials of a $300 generic hepatitis C regimen that could help expand treatment of the virus in poorer nations.
Pretty snappy heading, isn’t it. But it’s what I actually did. Via Twitter. So I got a lot of the info and got to skip the queues for taxis.
You have been inactive for 60 minutes and will be logged out in . Any updates not saved will be lost.
Click here to log back in.